Literature DB >> 6696635

The role of glycosylation on haemagglutination and immunological reactivity of rubella virus.

L Ho-Terry, A Cohen.   

Abstract

Treatment of purified rubella virus with mixed glycosidases resulted in loss of haemagglutinating (HA) activity but the capacity to combine with haemagglutination inhibiting (HI) and other antibodies was retained. Electrophoretic analysis revealed a greater effect on VPI than VPII.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6696635     DOI: 10.1007/bf01310807

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  7 in total

1.  The structural proteins of rubella virus.

Authors:  H Liebhaber; P A Gross
Journal:  Virology       Date:  1972-03       Impact factor: 3.616

2.  Degradation of rubella virus envelope components.

Authors:  L Ho-Terry; A Cohen
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

3.  Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum.

Authors:  H Liebhaber
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

4.  Glycosidase susceptibility: a probe for the distribution of glycoprotein oligosaccharides in Sindbis virus.

Authors:  M McCarthy; S C Harrison
Journal:  J Virol       Date:  1977-07       Impact factor: 5.103

5.  Measurement of rubella antibody by hemagglutination inhibition. I. Variables affecting rubella hemagglutination.

Authors:  H Liebhaber
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

6.  Effect of 2-mercaptoethanol on the haemagglutinating activity and antigenic properties of rubella virus.

Authors:  L Ho-Terry; A Cohen
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

7.  Evaluation of solid-phase enzyme-immunoassay procedure in immunity surveys and diagnosis of rubella.

Authors:  A Vaheri; E M Salonen
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

  7 in total
  11 in total

Review 1.  Rubella virus replication and links to teratogenicity.

Authors:  J Y Lee; D S Bowden
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Localization of the rubella E1 epitopes.

Authors:  G M Terry; L Ho-Terry; P Londesborough; K R Rees
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; D Ou; P Chong; S Gillam
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

5.  Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.

Authors:  H Seppänen; M L Huhtala; A Vaheri; M D Summers; C Oker-Blom
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

6.  A bio-engineered rubella E1 antigen.

Authors:  G M Terry; L Ho-Terry; P Londesborough; K R Rees
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

7.  Cryo-electron tomography of rubella virus.

Authors:  Anthony J Battisti; Joshua D Yoder; Pavel Plevka; Dennis C Winkler; Vidya Mangala Prasad; Richard J Kuhn; Teryl K Frey; Alasdair C Steven; Michael G Rossmann
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

8.  Assembly, maturation and three-dimensional helical structure of the teratogenic rubella virus.

Authors:  Vidya Mangala Prasad; Thomas Klose; Michael G Rossmann
Journal:  PLoS Pathog       Date:  2017-06-02       Impact factor: 6.823

Review 9.  Molecular biology of rubella virus.

Authors:  T K Frey
Journal:  Adv Virus Res       Date:  1994       Impact factor: 9.937

10.  Localization of the virus neutralizing and hemagglutinin epitopes of E1 glycoprotein of rubella virus.

Authors:  H Chaye; P Chong; B Tripet; B Brush; S Gillam
Journal:  Virology       Date:  1992-08       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.